Patients | |
Sex | |
Male | 37 (66.1 %) |
Female | 19 (33.9 %) |
Median age (range) | 70.4 years (42.7–87.0) |
≥ 70 years | 31 (55.4 %) |
< 70 years | 25 (44.6 %) |
Baseline Karnofsky Index | |
70 % (50–80 %) | |
Pulmonary function (median) | |
FEV1 (%) | 62 % (27.8–120.4 %) |
FEV1 (absolut) | 1.7 l (0.83–4.38 l) |
Smoking status | |
Active smokers | 25 (44.6 %) |
Former smokers | 20 (35.8 %) |
Never-smokers | 6 (10.7 %) |
Smoking status not known | 5 (8.9 %) |
Median packyears | 43 (20–120) |
Pulmonary lesions | |
TNM limited stage NSCLC patients | |
cT1cN0 | 14 |
cT2cN0 | 14 |
cT3cN0 | 0 |
cT4cN0 (further metastases in other lobe) | 2 |
TNM locally advanced NSCLC patients | |
cT1cN1-3 | 4 |
cT2cN1-3 | 1 |
Pulmonary metastases – primary tumors | |
NSCLC | 19 |
Breast cancer | 2 |
Renal cell carcinoma | 2 |
Prostate cancer | 1 |
Sarcoma | 1 |
Cancer of unkown primary | 1 |